Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5953466 | Chest | 2015 | 10 Pages |
Abstract
Despite receiving guideline-concordant antiinflammatory treatments at ED discharge, almost one in five patients relapsed within 4 weeks. Female sex, prolonged symptoms, treatment-related factors, and markers of prior asthma severity were significantly associated with relapse. These results may help physicians target more aggressive interventions for patients at high risk of relapse.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brian H. MD, FCCP, Cristina MD, Sumit R. MD, MPH, Riyad B. MD, MHSc, Shawn D. MD, Ian G. MD, Jeffrey PhD, Ambikaipakan PhD,